Year |
Citation |
Score |
2011 |
Ruchelman AL, Man HW, Chen R, Liu W, Lu L, Cedzik D, Zhang L, Leisten J, Collette A, Narla RK, Raymon HK, Muller GW. 1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4. Bioorganic & Medicinal Chemistry. 19: 6356-74. PMID 21955454 DOI: 10.1016/j.bmc.2011.08.068 |
0.301 |
|
2006 |
Zhu S, Ruchelman AL, Zhou N, Liu A, Liu LF, LaVoie EJ. 6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity. Bioorganic & Medicinal Chemistry. 14: 3131-43. PMID 16412652 DOI: 10.1016/J.Bmc.2005.12.028 |
0.701 |
|
2005 |
Zhu S, Ruchelman AL, Zhou N, Liu AA, Liu LF, LaVoie EJ. Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents. Bioorganic & Medicinal Chemistry. 13: 6782-94. PMID 16153852 DOI: 10.1016/J.Bmc.2005.07.033 |
0.668 |
|
2005 |
Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ. 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance. Journal of Medicinal Chemistry. 48: 792-804. PMID 15689163 DOI: 10.1021/Jm049447Z |
0.64 |
|
2004 |
Ruchelman AL, Zhu S, Zhou N, Liu A, Liu LF, LaVoie EJ. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity. Bioorganic & Medicinal Chemistry Letters. 14: 5585-9. PMID 15482929 DOI: 10.1016/J.Bmcl.2004.08.070 |
0.716 |
|
2004 |
Ruchelman AL, Kerrigan JE, Li TK, Zhou N, Liu A, Liu LF, LaVoie EJ. Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity. Bioorganic & Medicinal Chemistry. 12: 3731-42. PMID 15186859 DOI: 10.1016/J.Bmc.2004.03.076 |
0.731 |
|
2004 |
Ruchelman AL, Singh SK, Ray A, Wu X, Yang JM, Zhou N, Liu A, Liu LF, LaVoie EJ. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity. Bioorganic & Medicinal Chemistry. 12: 795-806. PMID 14759740 DOI: 10.1016/J.Bmc.2003.10.061 |
0.722 |
|
2004 |
Ruchelman A, Singh S, Liu A, Zhou N, Liu L, La Voie E. Cytotoxicity of 5H-Dibenzo[c,h][1,6]naphthyridin-6-ones and 6H-Indeno[1,2-c]isoquinolin-5,11-diones in Tumor Cells Sensitive and Resistant to Camptothecin Analogs Letters in Drug Design & Discovery. 1: 198-202. DOI: 10.2174/1570180043399064 |
0.502 |
|
2003 |
Li TK, Houghton PJ, Desai SD, Daroui P, Liu AA, Hars ES, Ruchelman AL, LaVoie EJ, Liu LF. Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Research. 63: 8400-7. PMID 14679002 |
0.595 |
|
2003 |
Kerrigan JE, Pilch DS, Ruchelman AL, Zhou N, Liu A, Liu L, LaVoie EJ. 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation. Bioorganic & Medicinal Chemistry Letters. 13: 3395-9. PMID 14505635 DOI: 10.1016/S0960-894X(03)00797-2 |
0.584 |
|
2003 |
Singh SK, Ruchelman AL, Li TK, Liu A, Liu LF, LaVoie EJ. Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity. Journal of Medicinal Chemistry. 46: 2254-7. PMID 12747798 DOI: 10.1021/Jm020498A |
0.725 |
|
2003 |
Ruchelman AL, Singh SK, Ray A, Wu XH, Yang JM, Li TK, Liu A, Liu LF, LaVoie EJ. 5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity. Bioorganic & Medicinal Chemistry. 11: 2061-73. PMID 12670657 DOI: 10.1016/S0968-0896(03)00051-8 |
0.719 |
|
2003 |
Singh SK, Ruchelman AL, Zhou N, Li TK, Liu A, Liu LF, LaVoie EJ. Aza-analogs of dibenzo[c,h]cinnoline: Triazachrysenes as potent topoisomerase I-targeting anticancer agents Medicinal Chemistry Research. 12: 1-12. |
0.698 |
|
2002 |
Ruchelman AL, Singh SK, Wu X, Ray A, Yang JM, Li TK, Liu A, Liu LF, LaVoie EJ. Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435. Bioorganic & Medicinal Chemistry Letters. 12: 3333-6. PMID 12392745 DOI: 10.1016/S0960-894X(02)00737-0 |
0.638 |
|
Show low-probability matches. |